Med Life SA · BVB:M

Med Life SA — H1 2019 Earnings Presentation

14 slides from Med Life SA's earnings presentation, 2019

  1. Slide 1: Conference Call Presentation for H1 2019 Financial Results

    Conference Call Presentation for H1 2019 Financial Results

  2. Slide 2: Legal Disclaimer

    LEGAL DISCLAIMER This presentation is not, and nothing in it should be construed as, an offer, invitation or recommendation in respect of Med Life SA’s securities, or an offer, invitation or recommendation to sell, or a solicitation of an offer to buy Med Life SA’s securities. Neither this presentat

  3. Slide 3: Topics of Discussion

    TOPICS OF DISCUSSION I. MAIN EVENTS OF H1 2019 AND SUBSEQUENT EVENTS 4 I. KEY CHANGES H1 2019 vs H1 2018 5 II. MEDLIFE H1 2019 FINANCIAL SNAPSHOT 8 III. KEY OPERATIONAL METRICS FOR H1 2019 11 IV. Q&A SESSION 12

  4. Slide 4: Main Events of H1 2019 and Subsequent Events

    MAIN EVENTS OF H1 2019 AND SUBSEQUENT EVENTS ACQUISITIONS • 51% of the shares in RMC Group, Hungary (finalized in March 2019) • 65% of the shares in Badea Medica Center of Excellence in Cluj (finalized in May 2019) • Increase from 55% to 90% shares in Sama Group, Craiova • Increase from 80% to 83% s

  5. Slide 5: Key Changes H1 2019 vs H1 2018

    KEY CHANGES H1 2019 vs H1 2018 Sales increased by : + 23.4% Pro-forma H1 2019 vs. IFRS H1 2018 SALES + 25.4% IFRS H1 2019 vs. IFRS H1 2018 + 15% like2like Improved margin: Before applying IFRS 16: 13% Pro-forma H1 2019 vs. 11.6% IFRS H1 2018 (fig_1 below) After applying IFRS 16: 17% Pro-forma H1 201

  6. Slide 6: Key Changes H1 2019 vs H1 2018 (Cont.)

    KEY CHANGES H1 2019 vs H1 2018 (Cont.) Split of Pro-forma EBITDA between Owners of the Group / NCI for H1 2019: 10.6% - 89.4% to Group Owners 89.4% - 10.6% to NCI EBITDA Vs. - 88.3% to Group Owners for IFRS H1 2018 Pro-forma EBITDA to Group Owners - 11.7% to NCI for IFRS H1 2018 Pro-forma EBITDA to

  7. Slide 7: Key Changes H1 2019 vs H1 2018 (Cont.)

    KEY CHANGES H1 2019 vs H1 2018 (Cont.) Absolute value of Net Result increased by: Before applying IFRS 16: 150.4% Pro-forma H1 2019 vs. IFRS H1 2018 After applying IFRS 16: 130.2% Pro-forma H1 2019 vs. IFRS H1 2018 NET RESULT - Split of Net Result IFRS H1 2019, before applying IFRS 16: 69% Owners /

  8. Slide 8: MedLife Group H1 2019 Financial Snapshot

    MEDLIFE GROUP H1 2019 FINANCIAL SNAPSHOT Consolidated Statement of Financial Position IFRS 16 adjustments: 1. Right-of-use asset : 97,680,895 RON; 2. Lease liability (current and long term): 98,603,108 RON; 3. Deferred tax liability: 308,182 RON; and 4. Impact in net result: (1,230,395) RON. Page 8

  9. Slide 9: MedLife Group Snapshot: Consolidated Statement of Profit and Loss

    MEDLIFE GROUP H1 2019 FINANCIAL SNAPSHOT(Cont.) Consolidated Statement of Profit and Loss IFRS 16 adjustments: 1. Rent: release of 18,461,436 RON from Rent expense; 2. Depreciation: additional 17,457,510 RON in Depreciation expense; 3. EBITDA: increase of 18,461,436 RON; 4. Financial result: additio

  10. Slide 10: MedLife Group Snapshot: Consolidated Statement of Cash Flow

    MEDLIFE GROUP H1 2019 FINANCIAL SNAPSHOT(Cont.) Consolidated Statement of Cash Flow Page 10

  11. Slide 11: MedLife Group Snapshot: OPEX Evolution

    MEDLIFE GROUP H1 2019 FINANCIAL SNAPSHOT(Cont.) OPEX Evolution Note: The Group recorded a 1.1 p.p. decrease of Operating Expenses as % of Sales in H1 2019 as compared to H1 2018: A. 4.9 p.p. decrease of “Rent” as % of Sales, generated by first time adoption of IFRS 16; B. 1.1 p.p. increase of “Third

  12. Slide 12: Key Operational Metrics for H1 2019

    KEY OPERATIONAL METICS FOR H1 2019 Page 12

  13. Slide 13: IV. Q&A Session

    © Med Life IV. Q&A SESSION RHSNe Page 13

  14. Slide 14: Thank You!

    THANK YOU! © MedLife

MedLife — H1 2019 Earnings Presentation on 6ix